Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13

BLOOD CANCER JOURNAL

SPRINGERNATURE

1. National Institutes of Health Specialized Programs of Research Excellence (SPORE) [P50100707, R01CA207237, PO1 CA155258, RO1 CA050947]
2. Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
3. Riney Family Multiple Myeloma Initiative